3,5-di-iso-propyl-heptatrienoic acid derivatives having serum glucose reducing activity
US6759546B1 · kind B1 · utility
0Cited by
5References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 4, 2003 |
| Grant date | Jul 6, 2004 |
| Priority date | — |
| Expiry date | Feb 4, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C69/734
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds of the formula where the variables have the meaning defined in the specification are capable of reducing serum glucose levels in diabetic mammals without the undesirable side effect of reducing serum thyroxine levels.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.